Spero Therapeutics Inc (SPRO)
1.175
-0.02
(-1.26%)
USD |
NASDAQ |
Nov 22, 16:00
1.175
0.00 (0.00%)
After-Hours: 20:00
Spero Therapeutics Shareholders Equity (Quarterly): 65.51M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 65.51M |
| June 30, 2024 | 80.50M |
| March 31, 2024 | 96.25M |
| December 31, 2023 | 106.89M |
| September 30, 2023 | 53.70M |
| June 30, 2023 | 54.78M |
| March 31, 2023 | 64.84M |
| December 31, 2022 | 75.93M |
| September 30, 2022 | 32.48M |
| June 30, 2022 | 35.92M |
| March 31, 2022 | 62.47M |
| December 31, 2021 | 88.29M |
| September 30, 2021 | 111.90M |
| June 30, 2021 | 90.25M |
| March 31, 2021 | 118.85M |
| December 31, 2020 | 132.04M |
| Date | Value |
|---|---|
| September 30, 2020 | 132.79M |
| June 30, 2020 | 73.71M |
| March 31, 2020 | 82.43M |
| December 31, 2019 | 74.57M |
| September 30, 2019 | 92.68M |
| June 30, 2019 | 109.31M |
| March 31, 2019 | 112.97M |
| December 31, 2018 | 115.50M |
| September 30, 2018 | 125.20M |
| June 30, 2018 | 65.31M |
| March 31, 2018 | 74.54M |
| December 31, 2017 | 84.60M |
| September 30, 2017 | 23.92M |
| June 30, 2017 | 31.78M |
| December 31, 2016 | 10.17M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
32.48M
Minimum
Sep 2022
132.79M
Maximum
Sep 2020
81.71M
Average
78.22M
Median
Shareholders Equity (Quarterly) Benchmarks
| CytomX Therapeutics Inc | -23.45M |
| Johnson & Johnson | 70.16B |
| Arbutus Biopharma Corp | 106.89M |
| Equillium Inc | 23.18M |
| NovaBay Pharmaceuticals Inc | 1.072M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 135.16M |
| Total Liabilities (Quarterly) | 69.65M |
| Current Ratio | 2.681 |